drugset / Trial / NCT05284448

Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis

NCT05284448

Phase 3 Completed 50 enrolled Al-Azhar University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the present study is to evaluate the efficacy and safety of pentoxifylline in the treatment of non-alcoholic steatohepatitis patients.

Timeline

Start
2022-02-01
Primary completion
2022-09-01
Completion
2022-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule 400 mg